Statement by Diane VanDe Hei, Executive Director, Association of Metropolitan Water Agencies
WASHINGTON, March 11 /PRNewswire-USNewswire/ -- Pharmaceutical residues found in our water supplies are a concern that metropolitan drinking water utilities take very seriously. While the scientific community does not yet know of any human health effects from trace amounts of these chemicals, the water sector is committed to finding out. Drinking water providers work closely with public health specialists, and consumers with health-related questions should contact their local health departments or their doctors.
Recognizing that consumers need information to make personal choices and water utilities need data to make informed decisions on treatment options, the water sector has not waited for U.S. EPA or FDA to address pharmaceuticals found in water. Our attention to this issue is demonstrated by the ongoing work of water research organizations and through proactive monitoring carried out by water utilities. The media has been proactive, too, by reporting on this subject for a decade or more.
Water treatment significantly reduces the concentration of pharmaceuticals in water, but water suppliers have made a priority of learning more about removing trace amounts that may be found after treatment.
The solution to this problem does not end with advancements in water treatment, however. We also need to be protecting the environment and our sources of drinking water. A comprehensive solution requires the collective effort of the federal government, animal feeding and production operations, water utilities and consumers.
Here are some recommendations of the Association of Metropolitan Water Agencies:
-- AMWA strongly encourages U.S. EPA to make research into treatment technologies a high priority.
-- U.S. EPA and FDA must address whether the presence of trace amounts
of pharmaceuticals result in short-term or lo
'/>"/>
| SOURCE Association of Metropolitan Water Agencies Copyright©2008 PR Newswire. All rights reserved |